Envision 2026: Clinical Research, Reimagined

Envision focuses on advancing clinical research and accelerating the path from innovation to patient care. This year, we’re taking a closer look at what sets Houston apart as a hub for clinical research and how TMC is exploring strategies to address the roadblocks Houston and Texas face today when it comes to clinical trial efficiency.

In collaboration with leading TMC member institutions, including UT MD Anderson Cancer Center, Baylor College of Medicine, UTHealth Houston, UTMB Health, Houston Methodist, and partners across the broader healthcare ecosystem, we are bringing together researchers, clinicians, industry leaders, and investors, helping to advance first-in-human and early-stage clinical trials.

You're invited to join us in exploring TMC’s clinical research platform across oncology, neuroscience, cardiovascular disease, and other high-impact therapeutic areas on Wednesday, November 11, 2026, at the TMC Innovation Factory.